A detailed history of Heron Financial Group, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Heron Financial Group, LLC holds 7,844 shares of MRK stock, worth $808,873. This represents 0.49% of its overall portfolio holdings.

Number of Shares
7,844
Previous 7,539 4.05%
Holding current value
$808,873
Previous $802,000 12.84%
% of portfolio
0.49%
Previous 0.44%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

BUY
$108.61 - $118.38 $33,126 - $36,105
305 Added 4.05%
7,844 $905,000
Q1 2023

Apr 19, 2023

BUY
$102.94 - $114.86 $68,558 - $76,496
666 Added 9.69%
7,539 $802,000
Q4 2022

Feb 14, 2023

BUY
$87.44 - $112.11 $52,464 - $67,266
600 Added 9.56%
6,873 $762,000
Q3 2022

Oct 27, 2022

BUY
$84.53 - $94.96 $13,102 - $14,718
155 Added 2.53%
6,273 $540,000
Q2 2022

Jul 29, 2022

SELL
$83.49 - $94.64 $88,081 - $99,845
-1,055 Reduced 14.71%
6,118 $558,000
Q1 2022

May 12, 2022

BUY
$73.51 - $82.4 $130,553 - $146,342
1,776 Added 32.91%
7,173 $589,000
Q4 2021

Feb 04, 2022

BUY
$72.28 - $90.54 $5,059 - $6,337
70 Added 1.31%
5,397 $442,000
Q3 2021

Nov 04, 2021

SELL
$71.68 - $78.83 $2,150 - $2,364
-30 Reduced 0.56%
5,327 $400,000
Q2 2021

Aug 16, 2021

BUY
$70.31 - $77.77 $46,053 - $50,939
655 Added 13.93%
5,357 $417,000
Q1 2021

Apr 14, 2021

BUY
$68.86 - $81.11 $59,219 - $69,754
860 Added 22.38%
4,702 $362,000
Q4 2020

Feb 16, 2021

SELL
$71.77 - $79.65 $3,947 - $4,380
-55 Reduced 1.41%
3,842 $323,000
Q3 2020

Oct 15, 2020

BUY
$73.18 - $82.95 $22,319 - $25,299
305 Added 8.49%
3,897 $317,000
Q2 2020

Jul 20, 2020

BUY
$70.42 - $80.13 $17,605 - $20,032
250 Added 7.48%
3,592 $276,000
Q4 2019

Feb 14, 2020

BUY
$77.58 - $87.54 $259,272 - $292,558
3,342 New
3,342 $285,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $261B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Heron Financial Group, LLC Portfolio

Follow Heron Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Heron Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Heron Financial Group, LLC with notifications on news.